| Name | inokosterone |
|---|---|
| Synonyms |
(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,6R)-2,3,7-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(22R)-2β,3β,14,20,22,26-Hexahydroxy-5β-cholest-7-en-6-one Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2-beta,3-beta,5-beta,22R)- (9ci) Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2β,3β,5β,22R) 5-beta-Cholest-7-en-6-one, 2-beta,3-beta,14,20,22,26-hexahydroxy-, (22R,25rs) Lnokosterone (2β,3β,5β,22R,25R)-2,3,14,20,22,26-Hexahydroxycholest-7-en-6-one 7, (5α)-CHOLESTEN-2β, 3β, 14, 20R, 22S, 25R-6-ONE 20(S)-Inokosterone |
| Description | Inokosterone is a potential drug target of estrogen receptor 1 in rheumatoid arthritis patients[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 713.2±60.0 °C at 760 mmHg |
| Melting Point | 255℃ (dec.) |
| Molecular Formula | C27H44O7 |
| Molecular Weight | 480.63 |
| Flash Point | 399.1±29.4 °C |
| Exact Mass | 480.308716 |
| PSA | 138.45000 |
| LogP | -0.46 |
| Vapour Pressure | 0.0±5.2 mmHg at 25°C |
| Index of Refraction | 1.596 |
| Hazard Codes | Xi |
|---|